CRI vs JNJ · P/E 7.0, rev $1.30B vs P/E 17, rev $49.37B
Carter’s Inc (CRI) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Carter’s Inc (CRI) is a apparel retail company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported CRI revenue for 2026-07-04 was $1.30B. Net income was $119.3M. Revenue was up 90.4% from 2026-04-04 to 2026-07-04. CRI currently screens at market cap $1.15B and trailing P/E 7.0.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
CRI currently screens at market cap $1.15B and trailing P/E 7.0. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the CRI and JNJ stock pages for the full models.
Not investment advice.